Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Guru Sonpavde: Clinical Trial Commentary - Is a Phase 1 Trial for Cancer Therapy a Good Option? - OncoDaily
38+ min ago (80+ words) Guru Sonpavde: Clinical Trial Commentary - Is a Phase 1 Trial for Cancer Therapy a Good Option? Oncodaily Guru Sonpavde: Clinical Trial Commentary – Is a Phase 1 Trial for Cancer Therapy a Good Option? Guru Sonpavde, GU Oncology and Phase I Clinical Trials…...
Felicia Marie Knaul: Dinner at San Angelin With Amazing Julie Gralow and Ana Carolina Sep??lveda
46+ min ago (101+ words) Felicia Marie Knaul: Dinner at San Angelin With Amazing Julie Gralow and Ana Carolina Sepúlveda Oncodaily Felicia Marie Knaul: Dinner at San Angelin With Amazing Julie Gralow and Ana Carolina Sepúlveda Felicia Marie Knaul, Associate of the Chancellor at UCLA,…...
Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy - OncoDaily
1+ hour, 21+ min ago (896+ words) Pulmonary adverse events remain one of the major challenges in thoracic radiotherapy, especially in patients who already have underlying lung disease. A new study published in Physics and Imaging in Radiation Oncology explored whether quantitative lung tissue functional analysis could…...
Swim Against Cancer: Bartłomiej Kubkowski’s Historic 160-Km Baltic Crossing - OncoDaily
1+ hour, 16+ min ago (705+ words) But the Baltic crossing became a challenge of a different scale. For several years, Kubkowski repeatedly returned to the sea despite unsuccessful attempts. The 2026 edition was promoted as his fifth and final attempt. This time, he reached the other side....
Julie Vose: Please Consider Donating for Establishing YIA in Biliary Cancer Honoring of Rachna Shroff - OncoDaily
9+ hour, 9+ min ago (70+ words) Julie Vose, Professor, Division of Hematology/Oncology at University of Nebraska Medical Center, shared on X: “Please consider donating to the ASCO Conquer Cancer Foundation endowed YIA in honor of Dr. Rachna Shroff. She is a shining star and a very…...
Lizza Hendriks: Breaking Barriers, Redefining Brain Metastases Treatment Concepts - OncoDaily
11+ hour, 40+ min ago (62+ words) Lizza Hendriks: Breaking Barriers, Redefining Brain Metastases Treatment Concepts oncodaily.com Nancy Lin, Breast Cancer Specialist and Director of EMBRACE MBC Program at Dana-Farber Cancer Institute, shared on X: “Brilliant keynote from Lizza Hendriks – ‘Breaking Barriers, Redefining Brain Metastases Treatment Concepts…...
Alicia Fong: What Does the Future of Cellular Therapy Look Like? - OncoDaily
16+ hour, 20+ min ago (67+ words) Alicia Fong, Research Assistant, Mount Sinai Health System, shared on LinkedIn: “What does the future of cellular therapy look like? M. Bilal Abid joins Medical Spotlight to discuss the evolving landscape of CAR-T therapy, the challenges surrounding access to cellular…...
Jean-Charles Soria: AI in Pharma R/D - Time to Move From Better Models to Better Medicines - OncoDaily
17+ hour, 15+ min ago (207+ words) Jean-Charles Soria: AI in Pharma R/D - Time to Move From Better Models to Better Medicines / AI drug discovery, AI in healthcare, AI in Pharma, AI models,, AI drug discovery, AI in healthcare, AI in Pharma, AI models, artificial intelligence,…...
Archi Rungta: How the Gut Microbiome Influences Anti-tumor Immunity
15+ hour, 6+ min ago (129+ words) Archi Rungta, Medical Research Fellow at Cancer Genetics Clinic MPMMCC VNS, shared on LinkedIn: “We are pleased to share our latest editorial published in the International Journal of Molecular and Immuno Oncology. This article explores how the gut microbiome influences…...
Herbert Loong: How Cognitive Complaints Shape Everyday Life for AYA Cancer Survivors
14+ hour, 52+ min ago (288+ words) Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, Advisor at Greater Bay Area International Clinical Trial Institute (GBAICTI), shared on LinkedIn: “‘Chemo brain’ doesn’t end when treatment does. Led by Yin Ting Cheung and her PhD…...